Zhengjun Qiu
- Cancer Research top 1%
- MicroRNA in disease regulation 23
- Cancer-related molecular mechanisms research 15
- Oncology top 5%
- Colorectal Cancer Surgical Treatments 10
- Pancreatic and Hepatic Oncology Research 6
- Molecular Biology top 5%
- Circular RNAs in diseases 15
- RNA modifications and cancer 12
- Immunology top 5%
-
- Gastric Cancer Management and Outcomes 12
-
- Cancer Mechanisms and Therapy 6
- Co-authors
- Chen HuangJun CaoKundong ZhangTao JiangXiaofeng WangKejian HuangGuangtao LuoZai Luo
- Partner nations
- ChinaUnited StatesThailand
In The Last Decade
Zhengjun Qiu
70 papers receiving 3.1k citations
Hit Papers
Peers
Comparison fields: 5 of 117
- Cancer Research 1.6k
- Oncology 852
- Molecular Biology 2.1k
- Immunology 500
- Pulmonary and Respiratory Medicine 398
Countries citing papers authored by Zhengjun Qiu
This map shows the geographic impact of Zhengjun Qiu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Zhengjun Qiu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Zhengjun Qiu more than expected).
Fields of papers citing papers by Zhengjun Qiu
This network shows the impact of papers produced by Zhengjun Qiu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Zhengjun Qiu. The network helps show where Zhengjun Qiu may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Zhengjun Qiu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2025 | 0 | |
| 3 | 2025 | 0 | |
| 4 | 2024 | 22 | |
| 5 | Lactylation of METTL16 promotes cuproptosis via m6A-modification on FDX1 mRNA in gastric cancerbreakdown → | 2023 | 264 |
| 6 | 2021 | 6 | |
| 7 | 2021 | 17 | |
| 8 | 2020 | 223 | |
| 9 | 2020 | 144 | |
| 10 | Hypoxic Tumor-Derived Exosomal miR-301a Mediates M2 Macrophage Polarization via PTEN/PI3Kγ to Promote Pancreatic Cancer Metastasisbreakdown → | 2018 | 580 |
| 11 | 2018 | 45 | |
| 12 | 2013 | 11 | |
| 13 | 2011 | 147 | |
| 14 | 2011 | 1 | |
| 15 | 2011 | 39 | |
| 16 | Expression of CD133 in pancreatic carcinoma and their clinicopathological significance | 2010 | 1 |
| 17 | 2009 | 23 | |
| 18 | 2009 | 9 | |
| 19 | 2007 | 104 | |
| 20 | 2007 | 66 |
About Zhengjun Qiu
Zhengjun Qiu is a scholar working on Cancer Research, Oncology and Health Informatics, having authored 78 papers that have together received 3.2k indexed citations. Recurring topics across this work include MicroRNA in disease regulation (23 papers), Cancer-related molecular mechanisms research (15 papers), Circular RNAs in diseases (15 papers), Gastric Cancer Management and Outcomes (12 papers), RNA modifications and cancer (12 papers), Colorectal Cancer Surgical Treatments (10 papers), Pancreatic and Hepatic Oncology Research (6 papers) and Cancer Mechanisms and Therapy (6 papers). The work is most often cited by research in Cancer Research (1.6k citations), Oncology (852 citations) and Molecular Biology (2.1k citations). Zhengjun Qiu has collaborated with scholars based in China, United States and Thailand. Frequent co-authors include Chen Huang, Jun Cao, Kundong Zhang, Tao Jiang, Xiaofeng Wang, Kejian Huang, Guangtao Luo, Zai Luo, Liping Su and Bingya Liu.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.